Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Clinical Applications of Radio-Frequency Ablation in Liver Metastasis of Colorectal Cancer

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2011³â 27±Ç 4È£ p.202 ~ 210
°ûÁöÈÆ, ¿Àº¸¿µ, À̾ƷÉ, Á¤¼ø¼·, ±è±¤È£,
¼Ò¼Ó »ó¼¼Á¤º¸
°ûÁöÈÆ ( Gwak Ji-Hun ) 
Ewha Womans University School of Medicine Department of Surgery

¿Àº¸¿µ ( Oh Bo-Young ) 
Ewha Womans University School of Medicine Department of Surgery
À̾Ʒɠ( Lee Ah-Ryung ) 
Ewha Womans University School of Medicine Department of Surgery
Á¤¼ø¼· ( Chung Soon-Sup ) 
Ewha Womans University School of Medicine Department of Surgery
±è±¤È£ ( Kim Kwang-Ho ) 
Ewha Womans University School of Medicine Department of Surgery

Abstract


Purpose: The aim of this study is to evaluate long-term survival and prognostic factors for radio-frequency ablation (RFA) in colorectal liver metastases.

Methods: We retrospectively reviewed 35 colorectal liver metastases patients who underwent RFA between 2004 and 2008. We analyzed survival after RFA and prognostic factors for survival.

Results: Of the 35 patients, 23 patients were male and 12 were female. Their mean age was 62.40 ¡¾ 12.52 years. Mean overall survival was 38.8 ¡¾ 4.6 months, and mean progression free survival was 19.9 ¡¾ 3.4 months. Three- and 5-year overall survival rates were 42.7 ¡¾ 0.1% and 26.0 ¡¾ 0.1%, respectively. Three- and 5-year progression-free survival rates were 19.6 ¡¾ 0.1% and 4.9 ¡¾ 0.04%, respectively. Overall survival and progression-free survival were significantly improved in male and in patients with carcinoembryonic antigen (CEA) ¡Â 100 ng/mL, carbohydrate antigen (CA) 19-9 ¡Â 100 ng/mL, absence of extrahepatic disease, and a unilobar hepatic lesion. In addition, progression-free survival was improved in patients with a solitary hepatic lesion. On the multivariate analysis, significant survival factors were the absence of extrahepatic disease and the presence of a unilobar hepatic lesion.

Conclusion: RFA for colorectal liver metastases is an effective treatment option in male patients and in patients with CEA or CA19-9 ¡Â 100, absence of extrahepatic disease, a solitary hepatic lesion, and a unilobar hepatic lesion.

Å°¿öµå

Radiofrequency ablation;Colorectal liver matastasis;Survival;Prognostic factor

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS